Pricing Log in Create free account

Alaunos Therapeutics, Inc. (TCRT) vs Tempest Therapeutics, Inc. (TPST)

Alaunos Therapeutics, Inc. and Tempest Therapeutics, Inc. are both Biotechnology companies. Alaunos Therapeutics, Inc. and Tempest Therapeutics, Inc. are of similar size ($7.6M and $7.5M). Alaunos Therapeutics, Inc. grew revenue faster over the last twelve months: −17.7% against −53.0%. Across the 12 metrics below, Alaunos Therapeutics, Inc. leads on 7 and Tempest Therapeutics, Inc. on 5.

Valuation

Metric TCRT TPST Biotechnology median
P/E n/m n/m 10.60
P/S 312.69 17.86 9.40
P/B 6.71 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1,408.11 22.37 9.02
Earnings yield (107.37%) (1,178.26%) (32.88%)
Free cash flow yield (30.18%) (365.85%) (23.13%)

Profitability

Metric TCRT TPST Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (185.95%) (931.14%) (51.96%)
Return on assets (128.30%) (237.25%) (46.06%)
Return on invested capital (480.35%) 0.00% 0.00%

Growth

Metric TCRT TPST Biotechnology median
Revenue growth (TTM) (17.65%) (52.98%) 6.76%
EPS growth (last fiscal year) 24.66% 67.55% 29.88%
Revenue growth, 5-year CAGR (49.08%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TCRT TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.77 0.38 4.97
Net debt to EBITDA 0.33 0.29 1.01

Dividend

Metric TCRT TPST Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric TCRT TPST Biotechnology median
Market cap 7.60m 7.50m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack